- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 60.97M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $275.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $210.9M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $57.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $91.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $278.4M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $241.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $677M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $579.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $664.8M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $642.5M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.88B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.77B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 61.6M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $100K |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $7.3M |
| Capex | Q1 2025 · Mar 31, 2024 | $8.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $31.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.04B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.84 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.85 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $51.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $54.3M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $116M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $308.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $424.9M |